↓ Skip to main content

Monitoring of Circulating Tumor DNA Predicts Response to Treatment and Early Progression in Follicular Lymphoma: Results of a Prospective Pilot Study

Overview of attention for article published in Clinical Cancer Research, October 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • Good Attention Score compared to outputs of the same age and source (65th percentile)

Mentioned by

news
1 news outlet
twitter
12 tweeters

Readers on

mendeley
8 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Monitoring of Circulating Tumor DNA Predicts Response to Treatment and Early Progression in Follicular Lymphoma: Results of a Prospective Pilot Study
Published in
Clinical Cancer Research, October 2022
DOI 10.1158/1078-0432.ccr-22-1654
Pubmed ID
Authors

Ismael Fernández-Miranda, Lucía Pedrosa, Marta Llanos, Fernando F. Franco, Sagrario Gómez, Paloma Martín-Acosta, Francisco R. García-Arroyo, Josep Gumá, Beatriz Horcajo, Ana K. Ballesteros, Laura Gálvez, Natividad Martínez, Miguel Marín, Silvia Sequero, Marta Navarro, Natalia Yanguas-Casás, Virginia Calvo, Antonio Rueda-Domínguez, Mariano Provencio, Margarita Sánchez-Beato

Twitter Demographics

The data shown below were collected from the profiles of 12 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 8 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 8 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 3 38%
Unspecified 2 25%
Student > Ph. D. Student 1 13%
Unknown 2 25%
Readers by discipline Count As %
Medicine and Dentistry 3 38%
Unspecified 2 25%
Immunology and Microbiology 1 13%
Unknown 2 25%

Attention Score in Context

This research output has an Altmetric Attention Score of 17. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 January 2023.
All research outputs
#1,824,937
of 22,988,380 outputs
Outputs from Clinical Cancer Research
#1,437
of 12,642 outputs
Outputs of similar age
#38,323
of 441,833 outputs
Outputs of similar age from Clinical Cancer Research
#38
of 110 outputs
Altmetric has tracked 22,988,380 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,642 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.9. This one has done well, scoring higher than 88% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 441,833 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 110 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 65% of its contemporaries.